Showing results (131-140 of 283) with videos related to
Sort By:
Pageof 29
Blood|January 15, 1991
Synergistic inhibition by verapamil and quinine of P-glycoprotein-mediated multidrug resistance in a human myeloma cell line modelM Lehnert, W S Dalton, D Roe, et al.International Journal of Biometeorology|January 17, 2020
Predicting the periodic risk of anthrax in livestock in Victoria, Australia, using meteorological dataT Brownlie, T Bishop, M Parry, et al.Cancer Research|October 1, 1978
Metabolism of [14C]spermidine and [14C]putrescine in normal volunteers and in cancer patientsM G Rosenblum, B G Durie, S E Salmon, et al.Clinical and Experimental Immunology|September 1, 1976
Intracytoplasmic and surface-bound immunoglobulins in "nonsecretory" and Bence-Jones myelomaJ L Preud'Homme, D Hurez, F Danon, et al.Journal of the National Cancer Institute|March 1, 1976
Membrane markers in "histiocytic" lymphomas (reticulum cell sarcomas)J C Brouet, J L Preud'Homme, G Flandrin, et al.The Journal of Clinical Investigation|November 1, 1970
Imbalances of gamma globulin subgroups and gene defects in patients with primary hypogammaglobulinemiaW J Yount, M Seligmann, R Hong, et al.Archives of Internal Medicine|June 1, 1979
mu-chain disease. Report of two new casesJ C Brouet, M Seligmann, F Danon, et al.Lancet (London, England)|November 8, 1975
Chronic lymphocytic leukaemia of T-cell origin. Immunological and clinical evaluation in eleven patientsJ C Brouet, M Sasportes, G Flandrin, et al.Cancer Treatment Reports|January 1, 1981
New drugs in ovarian cancer and malignant melanoma: in vitro phase II screening with the human tumor stem cell assayS E Salmon, F L Meyskens, D S Alberts, et al.Journal of the National Cancer Institute|May 3, 1989
Prediction of doxorubicin resistance in vitro in myeloma, lymphoma, and breast cancer by P-glycoprotein stainingS E Salmon, T M Grogan, T Miller, et al.Pageof 29